Genetic research and the collective good: participants as leaders

By Ilaria Galasso and Susi Geiger. Medical ethics has long centered around the question of how to balance the public or common good with individual rights. Different approaches to ethics would prioritize different values in the context of medical research participation. Well-established moral principles provide solid arguments both for an obligation to participate in medical […]

Read More…

Developing a practical resource to improve the ethical standing of gene therapy trials

By Rosie Munday, Hugh Davies and Stephanie Jones with Oxford “A” Health Research Authority Research Ethics Committee Oxford “A” NHS REC is one of the four UK Research Ethics Committees flagged to review gene therapy proposals. Following the philosopher Mary Warnock’s sage advice “I do not believe you can make moral judgements unless, as far […]

Read More…

Commercial DNA databases and criminal investigations: Why the customer should not be king

By Nina de Groot In a colorful envelop, tens of millions of people around the world have sent their cheek swabs to a commercial company with the same colors on its facade. By taking a DNA test, they hope to find out about long-lost relatives, their genetic susceptibility for breast cancer, athletic performance capabilities, or […]

Read More…

Expanding insurance coverage for in vitro fertilization with pre-implantation genetic testing

By Madison K. Kilbride When prospective parents learn that they’re at risk of passing a genetic condition to their future children, they’re often very concerned. Currently, there are two ways to ensure that one’s biological children do not inherit a hereditary condition. The first is to conceive naturally, use prenatal diagnosis to test the fetus […]

Read More…

Is the “serious” factor in germline modification really relevant? A response to Kleiderman, Ravitsky and Knoppers

By Iñigo de Miguel Beriain Is the “serious” factor in germline modification relevant? This seems a relevant question in the germline gene editing debate. Of course, at first glance, one tends to choose an affirmative answer immediately. It seems common sense to think that sophisticated technology should be used only when we are faced with […]

Read More…

‘Was this on the consent form?’ Can you really consent in a one-off conversation to interventions with uncertain and evolving consequences?

By Rachel Horton, Benjamin Bell, Angela Fenwick, Anneke Lucassen A child conceived with a donated egg has multiple health problems but no unifying diagnosis. Given that testing of biological parents may help make a genetic diagnosis in a child, is it OK to contact the child’s anonymous egg donor to ask if they would provide […]

Read More…